The White House announced that the U.S. plans to give 60 million doses of the AstraZeneca COVID-19 vaccine to countries around the world.
"The administration is looking at options to share American-made AstraZeneca vaccine doses during the next few months," said White House press secretary Jen Psaki. "Given AstraZeneca is not authorized for use in the United States, we do not need to use AstraZeneca in our fight against Covid over the next few months."
According to Psaki, the administration expects 10 million doses to be available "if or when the FDA gives its concurrence." Another 50 million doses are in various stages of development that could be available in the next couple months.
The White House has been looking into how it could "loan doses" to other countries, as the U.S. was reportedly planning on sending four million doses of the AstraZeneca vaccines to Mexico and Canada.
The FDA has not made an authorization decision for the AstraZeneca vaccine. According to The Associated Press, the administration of the vaccine in Europe was "halted in more than a dozen mostly European countries following scattered reports that a small number of people who had received it later experienced blood clots." However, European Union regulators have since announced that the vaccine is safe and not connected to an overall increase in the risk of blood clots.